rodman and renshaw just posted a very positive article about DRRX qtr report, giving a buy rating and $4 p/t.
also,
TipRanks analytics exhibit DURECT is a Strong Buy. Of 3 analysts polled in the last 3 months about DRRX stock, 100% rate a Buy. The stock’s consensus target price stands at $4.67, marking a significant nearly 154% upside from where the stock is currently trading.